Surgery, octreotide, temozolomide, bevacizumab, radiotherapy and pegvisomant treatment of an AIP mutation positive child

Multimodal treatment with surgery, octreotide-LAR, radiotherapy, temozolomide, bevacizumab and pegvisomant can control genetically driven aggressive childhood-onset somatotrophinomas.